The FDA has approved Amneal Pharmaceuticals’ ( NASDAQ: AMRX) OTC Naloxone HCl nasal spray, a generic version of the opioid ...
Opioid: As a doctor, I learned that Tennessee laws prohibit medical professionals from providing standard-of-care treatment.
By Chris Wack Amneal Pharmaceuticals shares were up 9% after the Food and Drug Administration approved an abbreviated new drug application ...
Vertex's VX-548, a non-opioid painkiller, is undergoing late-stage clinical trials and shows potential for FDA approval this ...
Amneal Announces U.S. FDA Approval of Over-the-Counter Naloxone Hydrochloride Nasal Spray for Emergency Treatment of an Opioid Overdose ...
Opinion: While Congress continues to discuss Alternatives to Prevent Addiction in the Nation (PAIN) Act, passing it seems ...
The IRA adds another hurdle to an already challenging research landscape, according to a study from the Pioneer Institute.
(RTTNews) - Amneal Pharmaceuticals, Inc. (AMRX) announced on Wednesday that it has received FDA approval for its Over the Counter Naloxone Hydrochloride or HCI Nasal Spray, USP, 4mg. This nasal spray ...
In addition to Narcan, sheriff's departments in at least three states have begun using another overdose reversal nasal spray ...
Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) announced on Monday that it has submitted its letter of ...
The school board’s policy committee recommended on Tuesday new rules on emergency use of Naloxone. The policy requires ...